A phase II trial to investigate the efficacy of gacyclidine (OTO-311) in patients with tinnitus

Trial Profile

A phase II trial to investigate the efficacy of gacyclidine (OTO-311) in patients with tinnitus

Planning
Phase of Trial: Phase II

Latest Information Update: 02 Mar 2017

At a glance

  • Drugs Gacyclidine (Primary)
  • Indications Tinnitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Mar 2017 According to an Otonomy media release, this trial is expected to start in the second half of 2017.
    • 20 Nov 2015 New trial record
    • 16 Nov 2015 This trial is expected to be initiated in the second half of 2016, according to an Otonomy media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top